Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:857380.
doi: 10.1155/2013/857380. Epub 2013 Oct 21.

Expression of VEGF-A, Otx homeobox and p53 family genes in proliferative vitreoretinopathy

Affiliations

Expression of VEGF-A, Otx homeobox and p53 family genes in proliferative vitreoretinopathy

Claudio Azzolini et al. Mediators Inflamm. 2013.

Abstract

Introduction: Proliferative vitreoretinopathy (PVR) is a severe inflammatory complication of retinal detachment. Pathological epiretinal membranes grow on the retina surface leading to contraction, and surgery fails in 5% to 10% of the cases. We evaluated the expression of VEGF-A, Otx1, Otx2, Otx3, and p53 family members from PVR specimens to correlate their role in inducing or preventing the pathology.

Methods: Twelve retinal samples were taken from patients affected by PVR during therapeutic retinectomies in vitreoretinal surgery. Gene expression was evaluated using quantitative real-time reverse transcriptase PCR analysis and immunohistochemistry, using four healthy human retinae as control.

Result: Controls showed basal expression of all genes. PVR samples showed little or no expression of Otx1 and variable expression of VEGF-A, Otx2, Otx3, p53, and p63 genes. Significant correlation was found among VEGF-A, Otx2, p53, and p63 and between Otx1 and Otx3.

Conclusions: Otx homeobox, p53 family, and VEGF-A genes are expressed in PVR human retina. We individuated two possible pathways (VEGF-A, Otx2, p53, p63 and Otx1 and Otx3) involved in PVR progression that could influence in different manners the course of the pathology. Individuating the genetic pathways of PVR represents a novel approach to PVR therapies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Important surgical steps. Left: peeling of epiretinal membranes using endoillumination and surgical instruments entering the eye through sclerotomies. Right: cut of peripheral retina (retinectomy) allowing further retinal reattachment.
Figure 2
Figure 2
Retina grasp. After retinectomy, a small retinal portion is grasped with nontraumatic forceps and is removed from the eye.
Figure 3
Figure 3
Gene expression levels in adult healthy human samples and in patients affected by PVR. Gene levels were detected by quantitative PCR. 2−ΔΔCt values representing gene expression are shown on y-axis. Black column: adult human samples as controls; gray columns: PVR affected patients. VEGF-A, Otx2, p53, and p63 show the similar expression trend, inversely to Otx1 and Otx3.
Figure 4
Figure 4
Statistical correlation among VEGF-A, Otx2, p53, and p63 genes and between Otx1 and Otx3 genes. Dispersion plots correlate two genes for graphic. x- and y-axes indicate 2−ΔΔCt values that represent gene expression levels. Linear regression coefficient (R) > 0.80 indicates a statistically significant correlation.
Figure 5
Figure 5
Histological section of healthy adult human retina. The different retinal layers appear marked in dark-marron with rabbit anti-Otx2 polyclonal antibody. Positivity is shown (from top to bottom) in photoreceptors, horizontal, bipolar, and neuronal cells (asterisks). An artifact (empty space) is present due to fixating procedure (star).

Similar articles

Cited by

References

    1. Charles S, Calzada J. Vitreous Microsurgery. 5th edition. Philadelphia, Pa, USA: Lippincott Williams & Wilkins; 2010.
    1. Leiderman YI, Miller JW. Proliferative vitreoretinopathy: pathobiology and therapeutic targets. Seminars in Ophthalmology. 2009;24(2):62–69. - PubMed
    1. Ricker LJ, Kessels AGH, de Jager W, Hendrikse F, Kijlstra A, la Heij EC. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling. The American Journal of Ophthalmology. 2012;154(2):347.e2–354.e2. - PubMed
    1. Pennock S, Rheaume M, Mukai S, Kazlauskas A. A novel strategy to develop therapeutic approaches to prevent proliferative vitreoretinopathy. The American Journal of Pathology. 2011;179(6):2931–2940. - PMC - PubMed
    1. Symeonidis C, Papakonstantinou E, Androudi S, et al. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade. Cytokine. 2012;59(1):184–190. - PubMed

Publication types